These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 36222846)

  • 1. The Mutational Landscape of Cancer's Vulnerability to Ionizing Radiation.
    Gopal P; Yard BD; Petty A; Lal JC; Bera TK; Hoang TQ; Buhimschi AD; Abazeed ME
    Clin Cancer Res; 2022 Dec; 28(24):5343-5358. PubMed ID: 36222846
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of KEAP1/NRF2 and TP53 Mutations in Lung Squamous Cell Carcinoma Development and Radiation Resistance.
    Jeong Y; Hoang NT; Lovejoy A; Stehr H; Newman AM; Gentles AJ; Kong W; Truong D; Martin S; Chaudhuri A; Heiser D; Zhou L; Say C; Carter JN; Hiniker SM; Loo BW; West RB; Beachy P; Alizadeh AA; Diehn M
    Cancer Discov; 2017 Jan; 7(1):86-101. PubMed ID: 27663899
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    Sitthideatphaiboon P; Galan-Cobo A; Negrao MV; Qu X; Poteete A; Zhang F; Liu DD; Lewis WE; Kemp HN; Lewis J; Rinsurongkawong W; Giri U; Lee JJ; Zhang J; Roth JA; Swisher S; Heymach JV
    Clin Cancer Res; 2021 Mar; 27(6):1720-1733. PubMed ID: 33323404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of anti-oxidant Keap1/Nrf2 pathway modulates efficacy of dihydroartemisinin-based monotherapy and combinatory therapy with ionizing radiation.
    Bader S; Wilmers J; Pelzer M; Jendrossek V; Rudner J
    Free Radic Biol Med; 2021 May; 168():44-54. PubMed ID: 33775773
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene-expression signature regulated by the KEAP1-NRF2-CUL3 axis is associated with a poor prognosis in head and neck squamous cell cancer.
    Namani A; Matiur Rahaman M; Chen M; Tang X
    BMC Cancer; 2018 Jan; 18(1):46. PubMed ID: 29306329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and Pathological Characteristics of
    Frank R; Scheffler M; Merkelbach-Bruse S; Ihle MA; Kron A; Rauer M; Ueckeroth F; König K; Michels S; Fischer R; Eisert A; Fassunke J; Heydt C; Serke M; Ko YD; Gerigk U; Geist T; Kaminsky B; Heukamp LC; Clement-Ziza M; Büttner R; Wolf J
    Clin Cancer Res; 2018 Jul; 24(13):3087-3096. PubMed ID: 29615460
    [No Abstract]   [Full Text] [Related]  

  • 7. Identification of novel Nrf2/Keap1 pathway mutations in pediatric acute lymphoblastic leukemia.
    Akın-Balı DF; Aktas SH; Unal MA; Kankılıc T
    Pediatr Hematol Oncol; 2020 Feb; 37(1):58-75. PubMed ID: 31661353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinicopathological, microenvironmental and genetic determinants of molecular subtypes in KEAP1/NRF2-mutant lung cancer.
    Cai MC; Chen M; Ma P; Wu J; Lu H; Zhang S; Liu J; Zhao X; Zhuang G; Yu Z; Fu Y
    Int J Cancer; 2019 Feb; 144(4):788-801. PubMed ID: 30411339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A genetic basis for the variation in the vulnerability of cancer to DNA damage.
    Yard BD; Adams DJ; Chie EK; Tamayo P; Battaglia JS; Gopal P; Rogacki K; Pearson BE; Phillips J; Raymond DP; Pennell NA; Almeida F; Cheah JH; Clemons PA; Shamji A; Peacock CD; Schreiber SL; Hammerman PS; Abazeed ME
    Nat Commun; 2016 Apr; 7():11428. PubMed ID: 27109210
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of Tumor Mutational Burden and Gene Alterations Associated with Radiation Response on Outcomes of Postoperative Radiation Therapy in Non-Small Cell Lung Cancer.
    Shaverdian N; Shepherd AF; Li X; Offin M; Lengel HB; Gelblum DY; Wu AJ; Simone CB; Rimner A; Jones DR; Chaft JE; Riaz N; Gomez DR
    Int J Radiat Oncol Biol Phys; 2022 Jun; 113(2):335-344. PubMed ID: 35157996
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of KEAP1/NFE2L2 Mutations in the Chemotherapeutic Response of Patients with Non-Small Cell Lung Cancer.
    Jeong Y; Hellyer JA; Stehr H; Hoang NT; Niu X; Das M; Padda SK; Ramchandran K; Neal JW; Wakelee H; Diehn M
    Clin Cancer Res; 2020 Jan; 26(1):274-281. PubMed ID: 31548347
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutations in the KEAP1-NFE2L2 Pathway Define a Molecular Subset of Rapidly Progressing Lung Adenocarcinoma.
    Goeman F; De Nicola F; Scalera S; Sperati F; Gallo E; Ciuffreda L; Pallocca M; Pizzuti L; Krasniqi E; Barchiesi G; Vici P; Barba M; Buglioni S; Casini B; Visca P; Pescarmona E; Mazzotta M; De Maria R; Fanciulli M; Ciliberto G; Maugeri-Saccà M
    J Thorac Oncol; 2019 Nov; 14(11):1924-1934. PubMed ID: 31323387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mazes of Nrf2 Regulation.
    Zenkov NK; Kozhin PM; Chechushkov AV; Martinovich GG; Kandalintseva NV; Menshchikova EB
    Biochemistry (Mosc); 2017 May; 82(5):556-564. PubMed ID: 28601065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of Radioresponsive Genes in Esophageal Cancer from Longitudinal and Single Cell Exome Sequencing.
    Yang L; Zhang X; MacKay M; Foox J; Hou Q; Zheng X; Zhou R; Huang M; Jing Z; Mason CE; Wu S
    Int J Radiat Oncol Biol Phys; 2020 Nov; 108(4):1103-1114. PubMed ID: 32561500
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interdisciplinary Study of the Effects of Dipeptidyl-Peptidase III Cancer Mutations on the KEAP1-NRF2 Signaling Pathway.
    Matić S; Tomašić Paić A; Sobočanec S; Pinterić M; Pipalović G; Martinčić M; Matovina M; Tomić S
    Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LKB1 and KEAP1/NRF2 Pathways Cooperatively Promote Metabolic Reprogramming with Enhanced Glutamine Dependence in
    Galan-Cobo A; Sitthideatphaiboon P; Qu X; Poteete A; Pisegna MA; Tong P; Chen PH; Boroughs LK; Rodriguez MLM; Zhang W; Parlati F; Wang J; Gandhi V; Skoulidis F; DeBerardinis RJ; Minna JD; Heymach JV
    Cancer Res; 2019 Jul; 79(13):3251-3267. PubMed ID: 31040157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dysfunctional KEAP1-NRF2 interaction in non-small-cell lung cancer.
    Singh A; Misra V; Thimmulappa RK; Lee H; Ames S; Hoque MO; Herman JG; Baylin SB; Sidransky D; Gabrielson E; Brock MV; Biswal S
    PLoS Med; 2006 Oct; 3(10):e420. PubMed ID: 17020408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simultaneous K-ras activation and Keap1 deletion cause atrophy of pancreatic parenchyma.
    Hamada S; Shimosegawa T; Taguchi K; Nabeshima T; Yamamoto M; Masamune A
    Am J Physiol Gastrointest Liver Physiol; 2018 Jan; 314(1):G65-G74. PubMed ID: 28971839
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NFE2L2/KEAP1 Mutations Correlate with Higher Tumor Mutational Burden Value/PD-L1 Expression and Potentiate Improved Clinical Outcome with Immunotherapy.
    Xu X; Yang Y; Liu X; Cao N; Zhang P; Zhao S; Chen D; Li L; He Y; Dong X; Wang K; Lin H; Mao N; Liu L
    Oncologist; 2020 Jun; 25(6):e955-e963. PubMed ID: 32272498
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NRF2 activation induces NADH-reductive stress, providing a metabolic vulnerability in lung cancer.
    Weiss-Sadan T; Ge M; Hayashi M; Gohar M; Yao CH; de Groot A; Harry S; Carlin A; Fischer H; Shi L; Wei TY; Adelmann CH; Wolf K; Vornbäumen T; Dürr BR; Takahashi M; Richter M; Zhang J; Yang TY; Vijay V; Fisher DE; Hata AN; Haigis MC; Mostoslavsky R; Bardeesy N; Papagiannakopoulos T; Bar-Peled L
    Cell Metab; 2023 Mar; 35(3):487-503.e7. PubMed ID: 36841242
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.